FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

897211000001105: Alupent 20mg tablets (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17125701000001114 Alupent 20mg tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17125801000001117 Alupent 20mg tablets (Boehringer Ingelheim Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Is a Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Is a Orciprenaline 20mg tablets true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Is a Orciprenaline 20mg tablets false Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Orciprenaline sulfate false Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Orciprenaline false Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Is a Alupent true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Orciprenaline sulfate true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alupent 20mg tablets (Boehringer Ingelheim Ltd) 100 tablet 10 x 10 tablets Is pack of False Alupent 20mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Alupent 20mg tablets (Boehringer Ingelheim Ltd) 100 tablet 10 x 10 tablets Has AMP True Alupent 20mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start